Theranostic mesoporous platinum nanoplatform delivers halofuginone to remodel extracellular matrix of breast cancer without systematic toxicity.
Journal Information
Full Title: Bioeng Transl Med
Abbreviation: Bioeng Transl Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Engineering, Biomedical
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"CONFLICT OF INTEREST The authors declare no competing financial or non‐financial interests."
"We greatly appreciate the financial support from the National Natural Science Foundation of China (Nos. 82022034, 81871420, 31930020, 81920108029, and 81971738), and Jiangsu Province Natural Science Foundation of China (BK20200032). We sincerely thank the Core Facility of the First Affiliated Hospital of Nanjing Medical University for its help in the experiment."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025